At the end of March, DOGE directed the NIH to reduce contract spending across each of its 27 institutes and centers by roughly 35%.
 Adobe
From pandemic preparedness to precious frozen spit, NIH contract terminations cut deep The full extent of the disruptions caused by these cuts may take months to emerge, but some of the early fallout is starting to come into view. Read more. By Megan Molteni and Jason Mast |
|
 Agnese Morganti for STAT
As financial prospects for gene therapies dim, an ambitious charity picks up the torch For more than three decades, a Milan charity has funded research aimed at developing medicines for genetic diseases. Recently, though, it added an unusual new role — as a gene therapy company of sorts. Read more. By Andrew Joseph
 Photo illo: STAT; Screen capture via YouTube
Vinay Prasad, in his own words, outlines the philosophy he'll bring to the FDA People seeking roles in government are often careful about what they say in public, or at least somewhat hesitant to freely share their opinions. It's difficult to know exactly what's going on in their heads. Not Vinay Prasad. Read more. By STAT staff
In case you missed it |
|
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2025, All Rights Reserved. | |
|
No comments